Stock listing
A40D1S Stock Price, News, Filings & Events — Biocardia, Inc.
Selected listing: A40D1S · LS · EUR · DE
This page tracks Biocardia, Inc.'s A40D1S:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40D1S:LS. A40D1S:LS is the stock-level entry point for investors researching Biocardia, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A40D1S:LS
- Asset type
- Stock
- Market cap
- $17.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Biocardia, Inc. A40D1S:LS stock context
This page tracks Biocardia, Inc.'s A40D1S:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40D1S:LS. A40D1S:LS is the stock-level entry point for investors researching Biocardia, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Biocardia, Inc.
BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for...
August 24, 2026
BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results
August 12, 2026
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026
August 5, 2026
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities
June 18, 2026
BioCardia Announces $4.4 Million Financing
June 8, 2026
Biocardia, Inc. earnings calls
BioCardia, Inc. (BCDA) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
BioCardia, Inc. (BCDA) Q1 2026 Earnings Call
May 15, 2026 · Replay with transcript and chapters
BioCardia, Inc. (BCDA) Q4 2025 Earnings Call
March 24, 2026 · Replay with transcript and chapters
BioCardia, Inc. (BCDA) Q3 2025 Earnings Call
November 12, 2025 · Replay with transcript and chapters
BioCardia, Inc. (BCDA) Q2 2025 Earnings Call
August 11, 2025 · Replay with transcript and chapters
BioCardia, Inc. (BCDA) Q1 2025 Earnings Call
May 14, 2025 · Replay with transcript and chapters
Research Biocardia, Inc.
Biocardia, Inc. investor report
Review AI stock analysis and investor report context for A40D1S:LS.
Biocardia, Inc. company profile
View the public company page for Biocardia, Inc. on 6ix.
Biocardia, Inc. news
Read company news and market updates connected to Biocardia, Inc..
Biocardia, Inc. investor events
Find investor webinars, events, and replay context for Biocardia, Inc..
Alternate listings
BCDA:NASDAQ
US · USD
Alternate listing for Biocardia, Inc.; the primary context on this page is A40D1S:LS.
BCDA:BOATS
US · USD
Alternate listing for Biocardia, Inc.; the primary context on this page is A40D1S:LS.
6JU0:FWB
DE · EUR
Alternate listing for Biocardia, Inc.; the primary context on this page is A40D1S:LS.
6JU0:GETTEX
DE · EUR
Alternate listing for Biocardia, Inc.; the primary context on this page is A40D1S:LS.